about
Neuronal activity regulates astrocytic Nrf2 signalingMolecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell lineClinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case-control studyRare somatic cells from human breast tissue exhibit extensive lineage plasticityCardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2IAxial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis.The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration.Astrocytes increase the activity of synaptic GluN2B NMDA receptorsRegulatory T cells suppress muscle inflammation and injury in muscular dystrophy.T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.Activation of the Keap1/Nrf2 stress response pathway in autophagic vacuolar myopathiesComparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.Analysis of Mll1 deficiency identifies neurogenic transcriptional modules and Brn4 as a factor for direct astrocyte-to-neuron reprogramming.LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of 3 cases.Reply to Deighton et al.: Neuronal activity regulates distinct antioxidant pathways in neurons and astrocytesIncreased autophagy accelerates colchicine-induced muscle toxicity.Complex sarcolemmal invaginations mimicking myotendinous junctions in a case of Laing early-onset distal myopathy.Dermatomyositis with inclusion body myositis pathology.Assembly-dependent trafficking assays in the detection of receptor-receptor interactions.Infant botulism, type F, presenting at 54 hours of life.Amyloid polyneuropathy caused by wild-type transthyretin.CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia.Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy.Type B gamma-aminobutyric acid receptors modulate the function of the extracellular Ca2+-sensing receptor and cell differentiation in murine growth plate chondrocytes.Skeletal myopathy in Pompe disease: a failure of satellite cell activation?Novel interstitial 2.6 Mb deletion on 9q21 associated with multiple congenital anomaliesGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy Defects in Skeletal MyopathiesNeuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell interventionOvarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis: Topography and Composition of Immune Cell and Neuroglial Populations Is Compatible With an Autoimmune Mechanism of DiseaseCOL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic HeterogeneityEducational Case: Mitochondrial Myopathy
P50
Q28391157-A6E7DC0C-93AD-4E3C-84D5-C0BA6E7C6D24Q28476724-3F14C3A2-E3C2-4E5C-AF48-C2B92C28E355Q28482758-150B4439-5ACE-4D39-9420-3BBB6236A07FQ30537989-AB13B6C7-D7A4-4B36-9527-E560A0C9DD25Q33820866-6BA829F3-D1D5-43B0-9798-5419EAF1B473Q34268739-B924F467-2032-4485-8747-E033F15BF5C8Q35035622-DD1AC48D-DE34-4DE9-B9F0-317D4074B7C6Q35456908-9F3F7F58-D484-458C-A29A-1961188CF473Q36957496-C1C4554B-5265-440B-AE51-E734F09D3C08Q37228223-4EC19009-00B4-4C89-B21D-6D09D5C730C5Q37383534-B6CF95C7-8D03-4ACD-B968-400C992B9688Q37485423-72D4F07F-960B-40D1-8575-6217C801B212Q40283693-16F68A8E-26DA-4F2E-A418-839B0B0E89F5Q41925748-F463C1C5-3190-4D41-9C49-7537678075B5Q42568003-5FA85544-EE92-4CC8-A59C-207B8CD9218BQ43821019-D473A895-76B6-47F0-B27B-DD87D965E91FQ44240611-D83D0D79-3AE9-47FD-A8AB-468B4D62F3EEQ45923437-651B9235-D075-4262-B063-63BA80FC93CBQ45992716-810EEFF5-FE20-4DA4-AEDB-165E7E98E822Q45998016-9FF7175F-215A-49ED-AE11-F5E8F7FB6827Q46104326-E7C3142A-E171-4907-AE8A-B88458AE7CF6Q46351256-711DC2E8-EC42-432D-89D8-3BC5615100F7Q46767870-A2CF5781-ADFC-46B6-8F8E-500ED61AC642Q50086387-00B2969F-561C-40FC-B38E-657B05327E09Q59798245-2843323E-4D98-4D25-90CB-4303539ECE74Q62919515-37F27ADA-3938-4A08-97BB-15135BBC0918Q87139132-55701492-A35D-445C-8EEA-B3E2A83BAA66Q90594995-10863345-2F06-4EDF-B61E-8F466B71C03CQ90976358-7B0D985C-5255-4F9A-8171-E56A0AC01864Q91507591-8A9072E1-4CD8-4097-9507-BDB469BD5CCEQ91732551-DE40C8FB-C61D-4333-AB1F-69B080CFF679Q91901259-771B9BAA-3A5E-4859-ABDB-18748EEE9247
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marta Margeta
@ast
Marta Margeta
@en
Marta Margeta
@es
Marta Margeta
@nl
Marta Margeta
@sl
type
label
Marta Margeta
@ast
Marta Margeta
@en
Marta Margeta
@es
Marta Margeta
@nl
Marta Margeta
@sl
prefLabel
Marta Margeta
@ast
Marta Margeta
@en
Marta Margeta
@es
Marta Margeta
@nl
Marta Margeta
@sl
P106
P1153
6505685876
P21
P31
P496
0000-0001-6889-2488